Hester Biosciences P/E Ratio

HESTERBIO • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
27.5
High Valuation
High - Growth expectations or overvalued

Current Valuation Metrics

P/E Ratio 27.5
Current Price ₹1426.90
EPS (TTM) ₹33.89
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 47.21
Historical Range 24.92 - 74.69
Percentile 14.3%

Sector Context

Sector Average 47.64
Sector Median 25.5
Sector Rank #11 of 139
Sector Percentile 7.9%

Earnings Breakdown (TTM)

TTM EPS ₹49.94
Sept 2025 ₹16.85
Mar 2025 ₹1.82

Key P/E Ratio Insights for Hester Biosciences

  • Stock appears overvalued with PE of 27.5, suggesting caution for new investments
  • Current PE is 41.8% below historical average
  • Trading at discount to sector average PE of 47.64

P/E Ratio Historical Trend for Hester Biosciences

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 47.88 49.94 ₹2391.00 NSE High
2024 36.85 39.59 ₹1459.00 NSE High
2023 74.69 24.09 ₹1799.30 NSE High
2022 68.7 36.84 ₹2531.05 NSE High
2021 35.4 47.69 ₹1688.40 NSE High
2020 42.05 34.53 ₹1452.10 NSE High
2019 24.92 46.73 ₹1164.30 NSE Moderate

Sector P/E Ratio Comparison

Comparing Hester Biosciences with other companies in Healthcare sector
Sector Average
47.64
Sector Median
25.5
Lowest P/E
0.83
Highest P/E
898.7
Companies
139
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 0.83 ₹31 Low
Murae Organisor MURAE 2.86 ₹41 Low
Ind Swift Laboratories INDSWFTLAB 4.53 ₹1,133 Low
Amwill Health Care AMWILL 5.67 ₹64 Low
Brooks Laboratories BROOKS 6.14 ₹157 Low
Medicamen Organics MEDIORG 6.4 ₹27 Low
Zenith Drugs ZENITHDRUG 6.83 ₹69 Low
Unichem Laboratories UNICHEMLAB 7.15 ₹2,100 Low
Galaxy Medicare GML 7.41 ₹26 Low
Vasundhara Rasayans VRL 9.35 ₹34 Low